Home Latest

Our COVID-19 research

The Kirby Institute has wide-ranging expertise in the fields of infectious diseases and epidemic response. We conduct research across the full...
ITAC is an international multicentre, adaptive, randomised double-blind, placebo-controlled trial, aimed at assessing the safety, tolerability, and...
TICO is an adaptive, international, randomised, blinded, placebo controlled platform trial to evaluate the safety and efficacy of different...

Events